Hjem › Diffust stort B-celle lymfom › North Carolina › Durham
Diffust stort B-celle lymfom kliniske forsøg i Durham, NC
14 studier for Diffust stort B-celle lymfom søger deltagere på steder i og omkring Durham (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
RekruttererFase 2
- Duke Blood Cancer Center, Durham
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
RekruttererFase 3
- Duke University Medical Center, Durham
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
RekruttererFase 2
- University of North Carolina Medical Center ( Site 0136), Chapel Hill · 10 mi væk
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RekruttererFase 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 10 mi væk
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
RekruttererObservationsstudie
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RekruttererFase 3
- Duke Cancer Institute, Durham
DALY II USA/ MB-CART2019.1 for DLBCL
RekruttererFase 2
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RekruttererFase 1
- Duke University Medical Center, Durham
Registry of Older Patients With Cancer
RekruttererObservationsstudie
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi væk
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
RekruttererFase 1
- Duke Univerisity, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RekruttererObservationsstudie
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi væk
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RekruttererFase 1
- University of North Carolina, Chapel Hill · 10 mi væk
A Study of NX-1607 in Adults With Advanced Malignancies
RekruttererFase 1
- University of North Carolina, Chapel Hill · 10 mi væk
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
RekruttererFase 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi væk
Diffust stort B-celle lymfom forsøg i andre byer
- New York City, NY21 studier
- Baldwin Park, CA19 studier
- Chicago, IL18 studier
- Houston, TX17 studier
- Los Angeles, CA17 studier
- Boston, MA16 studier
- Milwaukee, WI16 studier
- Nashville, TN15 studier
- Portland, OR15 studier
- Philadelphia, PA15 studier
- Dallas, TX13 studier
- Seattle, WA12 studier
Andre studier i Durham
- Brystkræft63 studier
- Kræft (alle typer)58 studier
- Ikke-småcellet lungecancer39 studier
- Multipelt myelom37 studier
- Metastatisk cancer33 studier
- Akut myeloid leukæmi33 studier
- Lungecancer32 studier
- Prostatakræft32 studier
- Colorektal kræft28 studier
- Kronisk lymfatisk leukæmi27 studier
- Ægstockræft27 studier
- Hjertesvigt26 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.